Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitazoxanide in Treatment of COVID-19

NCT04382846 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT04382846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitazoxanide in Treatment of COVID-19
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Recruiting
Start date
May 8, 2020
Completion date
December 1, 2030
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid